Follow The Filings

NCLH Norwegian Cruise Line Holding

Consumer Discretionary, filed as NORWEGIAN CRUISE LINE HLDG L (SHS), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2

  • 1 Owner
  • $1K

Who owns NCLH

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust <0.01% Hold 100 $1K History

1 current, options excluded

Insider trades

Open-market buys and sales by NCLH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NCLH insider trades
  • $30.9M bought by 13 insiders
  • $110K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Stephen G Pagliuca Director
    Buy
    $25M 1,380,000 shares at $18.11 +15485% to stake
    Traded Jun 1–2 Filed Jun 3
    ↗
  2. John Chidsey CEO
    Buy
    $2.5M 153,000 shares at $16.37 +16% to stake
    Traded May 22 Filed May 26
    ↗
  3. Jonathan Z Cohen Director
    Buy
    $475K 30,000 shares at $15.83 +337% to stake
    Traded May 20 Filed May 21
    ↗
  4. Jose E. Cil Director
    Buy
    $225K 15,000 shares at $15.02 +25% to stake
    Traded May 18–19 Filed May 19
    ↗
  5. Brian P MacDonald Director
    Buy
    $248K 15,000 shares at $16.54 +168% to stake
    Traded May 11 Filed May 12
    ↗
  6. Kevin Allen Lansberry Director
    Buy
    $197K 11,400 shares at $17.28 +128% to stake
    Traded May 7 Filed May 11
    ↗
  7. Zillah Byng-Thorne Director
    Buy
    $521K 29,467 shares at $17.69
    Traded May 7 Filed May 11
    ↗
  8. Faye L. Ashby SVP & Chief Accounting Officer
    Sale
    $110K 5,250 shares at $21.00 3.9% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗
  9. Patrik Dahlgren EVP, Chief Vessel Ops & NO
    Buy
    $100K 5,550 shares at $17.94 +4% to stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  10. Harry C Curtis Director
    Buy
    $96K 5,000 shares at $19.25 +11% to stake
    Traded Nov 7, 2025 Filed Nov 12, 2025
    ↗
  11. Stella David Director
    Buy
    $130K 6,986 shares at $18.59 +7.2% to stake
    Traded Nov 6, 2025 Filed Nov 10, 2025
    ↗
  12. Zillah Byng-Thorne Director
    Buy
    $525K 29,008 shares at $18.11 +78% to stake
    Traded Nov 6, 2025 Filed Nov 10, 2025
    ↗
  13. Mark Kempa CFO
    Buy
    $197K 10,635 shares at $18.53 +3% to stake
    Traded Nov 6, 2025 Filed Nov 6, 2025
    ↗
  14. Jason Montague Chief Luxury Officer
    Buy
    $252K 13,400 shares at $18.81 New stake
    Traded Nov 6, 2025 Filed Nov 6, 2025
    ↗
  15. Harry Sommer Pres. & CEO of NCLH
    Buy
    $463K 25,000 shares at $18.52 +3.6% to stake
    Traded Nov 6, 2025 Filed Nov 6, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants and 16 share withholdings for taxes.

Congress

1 member of Congress traded NCLH in the last three years: 2 buys and 2 sales. 4 members listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 31, 2025 filed Nov 21, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Oct 30, 2025 filed Nov 21, 2025
  3. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 30, 2025 filed Nov 21, 2025
  4. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,1.02,2.03,8.01,9.01 Filing Doc
8-K 7.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K/A 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
8-K 8.01 Filing Doc

Source: SEC EDGAR submissions, updated about 21 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $8.55B $9.48B $9.83B
Gross profit * $3.08B $3.79B $4.19B
Gross margin * 36.0% 40.0% 42.6%
Net income $166.18M $910.26M $423.25M
Net margin * 1.9% 9.6% 4.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.31B $1.01B $1.14B
Total non-current assets * $18.18B $18.96B $21.4B
Total assets $19.49B $19.97B $22.54B
Total current liabilities $6.04B $5.78B $5.45B
Total non-current liabilities * $13.15B $12.76B $14.88B
Total equity $0.301B $1.43B $2.21B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $2.01B $2.05B $2.09B
Cash from investing -$2.9B -$1.23B -$3.26B
Cash from financing $0.347B -$1.03B $1.19B
Net change in cash -$544.57M -$211.65M $19.13M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.